Entacapone: A High-Purity Active Pharmaceutical Ingredient for Parkinson's Disease Treatment
Enhancing Parkinson's treatment with a selective COMT inhibitor, maximizing levodopa therapy.
Get a Quote & SampleProduct Core Value
Entacapone
Entacapone is a critical synthetic drug and an Active Pharmaceutical Ingredient (API) vital for the treatment of Parkinson's disease. As a selective and reversible catechol-O-methyl transferase (COMT) inhibitor, it plays a crucial role in optimizing levodopa therapy.
- Discover the benefits of using Entacapone CAS 130929-57-6 to manage Parkinson's disease symptoms effectively.
- Experience consistent quality with our Entacapone USP/EP grade, ensuring reliability in pharmaceutical applications.
- Achieve enhanced therapeutic outcomes by utilizing Entacapone for Parkinson's disease treatment, which boosts levodopa effectiveness.
- Investigate the mechanism of this selective reversible COMT inhibitor and its impact on neurological health.
Key Advantages of Entacapone
High Purity and Consistent Quality
Our Entacapone API boasts a purity of 99%, ensuring consistent quality and performance crucial for effective Parkinson's disease treatment.
Enhanced Levodopa Therapy
As a selective reversible COMT inhibitor, Entacapone significantly improves the efficacy of levodopa therapy, offering more sustained plasma levodopa concentrations.
Reliable Pharmaceutical Grade
Meeting USP/EP standards, this synthetic drug is a reliable choice for pharmaceutical formulations targeting neurological conditions.
Key Applications
Parkinson's Disease Treatment
Entacapone is primarily used to manage the symptoms of Parkinson's disease by inhibiting COMT, leading to better motor control and reduced fluctuations.
COMT Inhibition Therapy
As a COMT inhibitor synthetic drug, it offers a targeted approach in neurological treatment, optimizing the action of other medications.
Active Pharmaceutical Ingredient (API)
This high purity API is a fundamental component in the formulation of drugs aimed at improving the quality of life for patients with neurodegenerative disorders.
Research and Development
Entacapone is also utilized in R&D settings to further explore treatments for neurological conditions and understand enzyme inhibition mechanisms.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).